Viromed Medical AG | Finanzwire

Basculer en Français

9472	Companies
185370	Keywords
117721	Articles
99262	Press releases

Home
Companies
Viromed Medical AG

BRIEF

published on 12/03/2024 at 13:58, 1 year ago

Viromed Medical AG Announces Plan to Acquire pharmedix GmbH

Acquisition Healthcare Capital Increase Viromed Medical AG Pharmedix GmbH
PRESS RELEASE

published on 12/03/2024 at 13:53, 1 year ago

EQS-Adhoc: Viromed Medical AG plans to acquire all shares in pharmedix GmbH by means of a capital increase against a contribution in kind, excluding subscription rights.
Viromed Medical AG plans to acquire pharmedix GmbH through a capital increase, expanding their healthcare portfolio. The acquisition aims for a revenue growth of 35% in 2025

Acquisition Revenue Growth Capital Increase Viromed Medical AG Pharmedix GmbH
BRIEF

published on 11/29/2024 at 15:11, 1 year ago

Viromed Medical AG Halts Acquisition Plans, Shifts Focus to Strategic Innovation

Strategic Focus Viromed Medical AG ActivCell Group AG ViroCAP Device Acquisition Halt
PRESS RELEASE

published on 11/29/2024 at 15:06, 1 year ago

EQS-Adhoc: Viromed Medical AG will not acquire ActivCell Group AG and is focusing on another strategic option with greater added value
Viromed Medical AG cancels acquisition of ActivCell Group AG, exploring more valuable strategic options. Focus shifts to advancing innovative medical device ViroCAP

Acquisition Strategic Options Viromed Medical AG ViroCAP Innovative Medical Device
BRIEF

published on 11/26/2024 at 08:05, 1 year ago

Viromed Medical AG Advances Cold Plasma Research for Lung Health

Healthcare Innovation Antibiotic Resistance Viromed Medical AG Cold Plasma Ventilator-associated Pneumonia
PRESS RELEASE

published on 11/26/2024 at 08:00, 1 year ago

Viromed Medical AG: cold plasma as a digital antibiotic for the lungs
Viromed Medical AG is advancing research into cold plasma as a 'digital antibiotic' for improving treatment of ventilator-associated pneumonia, with potential to revolutionize healthcare

Viromed Medical AG Cold Plasma Ventilator-associated Pneumonia Healthcare Revolution Digital Antibiotic
BRIEF

published on 09/17/2024 at 15:45, 1 year 2 months ago

Viromed Medical AG Announces Plans to Acquire ActivCell Group AG

Mergers & Acquisitions Medical Device Regulation Viromed Medical AG Cold Plasma Therapy ActivCell Group AG
PRESS RELEASE

published on 09/17/2024 at 15:40, 1 year 2 months ago

EQS-Adhoc: Viromed Medical AG plans to acquire all shares of ActivCell Group AG by way of a capital increase against contribution in kind with exclusion of subscription rights
Viromed Medical AG plans to acquire all shares of ActivCell Group AG by capital increase excluding subscription rights, strategically expanding product portfolio

Acquisition Capital Increase Product Portfolio Viromed Medical AG ActivCell Group AG
BRIEF

published on 09/02/2024 at 10:05, 1 year 3 months ago

Viromed Medical AG: Successful Start of Trading on XETRA

XETRA Trading Growth Potential Investor Base Viromed Medical AG Cold Plasma Technology
PRESS RELEASE

published on 09/02/2024 at 10:00, 1 year 3 months ago

Viromed Medical AG: Successful start of trading on XETRA
Viromed Medical AG successfully starts trading on XETRA, aiming to expand cold plasma technology use in medical field, increase liquidity, and attract more investors

Liquidity XETRA Trading Investor Base Viromed Medical AG Cold Plasma Technology

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 42 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 47 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 17 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 12 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 17 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 07:00, 16 minutes ago

Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 46 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 26 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 51 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 2 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 17 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 32 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 33 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE